Hemab Therapeutics
Last verified 2026-05-22. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $325.0Mattributed |
|---|---|
| Latest round | series-c, $157.0M, 2025-10-01attributed |
| Founded | 2019 |
| Headquarters | Copenhagen, Denmark |
| Industry | bio |
| Stage | series-b+ |
| Website | hemab.com |
Clinical-stage biopharmaceutical company developing prophylactic therapies for bleeding and thrombotic disorders
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-01 | series-c | $157.0M | undisclosed |
Detected tech stack
Cloudflare, Typeform, Linkedin Insight Tag, Unpkg, Railway, Google Font API, Google Hosted Libraries, Facebook Pixel, Sirvoy, jsDelivr, HubSpot, cdnjs
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series C, $157.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $325.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | hemab.com, read 2026-05-22 |
| Description | self-reported | hemab.com, read 2026-05-22 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.